Literature DB >> 15844502

Symptomatic and pathophysiological observations in a modified animal model of allergic rhinitis.

Y Zhao1, John K S Woo, P C Leung, George G Chen, Y O Wong, S X Liu, C Andrew van Hasselt.   

Abstract

There are many animal models for studying allergic rhinitis. However, they either need a too long establishment period or fail to show significant late allergic responses. In the model described in this paper, guinea pigs were sensitized and challenged intranasally with ovalbumin according to a modified protocol. As controls, antihistamine-treatment and non-sensitized, non-treatment groups were studied in parallel. Early and late symptoms, passive cutaneous anaphylaxis (PCA) reaction, nitric oxide synthase (NOS) immunoreactivities, pathological changes in nasal mucosa and nasal lavage fluid (NLF), and histamine, TXB2 and p-LTs levels in NLF were evaluated. In contrast to the control groups, the model group exhibited typical symptoms, including late phase nasal blockage, and increased levels of IgG1 and IgE. Considerable eosinophil infiltration and eNOS immunoreactivities in nasal mucosa, and increased levels of histamine, TXB2 and p-LTs in NLF were also observed. This model was not only capable of showing satisfactory symptomatic and pathophysiological changes in allergic rhinitis but also showed good responses to antihistamine treatment. The model can be established in six weeks. For the first time, respiratory rate was employed as an index to reflect the nasal blockage of guinea pigs and it proved to be a reliable indicator.

Entities:  

Mesh:

Year:  2005        PMID: 15844502

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  5 in total

1.  Evaluation of a temperature-restricted, mucosal tuberculosis vaccine in guinea pigs.

Authors:  Tuhina Gupta; Monica LaGatta; Shelly Helms; Rebecca L Pavlicek; Simon O Owino; Kaori Sakamoto; Tamas Nagy; Stephen B Harvey; Mark Papania; Stephanie Ledden; Kevin T Schultz; Candace McCombs; Frederick D Quinn; Russell K Karls
Journal:  Tuberculosis (Edinb)       Date:  2018-10-19       Impact factor: 3.131

2.  Establishment of a new animal model of allergic rhinitis with biphasic sneezing by intranasal sensitization with Staphylococcal enterotoxin B.

Authors:  Rong Sun; Xinye Tang; Hongbing Yao; Suling Hong; Yang Yang; Wei Kou; Ping Wei
Journal:  Exp Ther Med       Date:  2015-05-21       Impact factor: 2.447

Review 3.  Rodent models of allergic rhinitis: relevance to human pathophysiology.

Authors:  James G Wagner; Jack R Harkema
Journal:  Curr Allergy Asthma Rep       Date:  2007-05       Impact factor: 4.806

4.  Bencycloquidium bromide inhibits nasal hypersecretion in a rat model of allergic rhinitis.

Authors:  Rui Long; Yuanda Zhou; Jiangju Huang; Li Peng; Long Meng; Shenyin Zhu; Juan Li
Journal:  Inflamm Res       Date:  2015-02-18       Impact factor: 4.575

5.  Honeysuckle extract relieves ovalbumin-induced allergic rhinitis by inhibiting AR-induced inflammation and autoimmunity.

Authors:  Bin Lin; Bijuan Cai; Huige Wang
Journal:  Biosci Rep       Date:  2019-07-29       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.